Results from the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation trial, however, showed similar relative efficacy of warfarin and rivaroxaban for stroke prevention in >5000 patients with T2D with atrial fibrillation.74 The gene discussed is F10; the disease is atrial fibrillation.